Thrombophilia and pregnancy complications

被引:8
作者
Brenner, Benjamin [1 ]
机构
[1] Bruce Rappaport Fac Med, Thrombosis & Hemostasis Unit, Rambam Med Ctr, IL-31096 Haifa, Israel
关键词
thrombophilia; pregnancy; coagulation; anti coagulant therapy;
D O I
10.1159/000093540
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Thrombophilic risk factors are common and can be found in 15% to 25% of Caucasian populations. Since pregnancy is an acquired hypercoagulable state, women harboring thrombophilia may present with clinical symptoms of vascular complications for the first time during gestation or at the postpartum period(1). Women with thrombophilia may have an increased risk of placental vascular complications, including pregnancy loss, preeclampsia, intrauterine growth restriction, and placental abruption. Accumulating data suggest that maternal antithrombotic prophylaxis may result in improved gestational outcome. Randomized trials are under way and hopefully will optimize maternal and neonatal outcome. Copyright (c) 2006 S. Karger AG, Basel.
引用
收藏
页码:28 / 35
页数:8
相关论文
共 58 条
[1]   Placental TFPI is decreased in gestational vascular complications and can be restored by maternal enoxaparin treatment [J].
Aharon, A ;
Lanir, N ;
Drugan, A ;
Brenner, B .
JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2005, 3 (10) :2355-2357
[2]   Tissue factor and tissue factor pathway inhibitor levels in trophoblast cells: implications for placental hemostasis [J].
Aharon, A ;
Brenner, B ;
Katz, T ;
Miyagi, Y ;
Lanir, N .
THROMBOSIS AND HAEMOSTASIS, 2004, 92 (04) :776-786
[3]   Factor V Leiden and factor II G20210A in preeclampsia and HELLP syndrome [J].
Benedetto, C ;
Marozio, L ;
Salton, L ;
Maulà, V ;
Chieppa, G ;
Massobrio, M .
ACTA OBSTETRICIA ET GYNECOLOGICA SCANDINAVICA, 2002, 81 (12) :1095-1100
[4]  
BREMME K, 1992, OBSTET GYNECOL, V80, P132
[5]   Haemostatic changes in pregnancy [J].
Bremme, KA .
BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY, 2003, 16 (02) :153-168
[6]  
Brenner B, 2000, THROMB HAEMOSTASIS, V83, P693
[7]   Thrombophilia and pregnancy loss in first intended pregnancy [J].
Brenner, B .
JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2005, 3 (10) :2176-2177
[8]   Efficacy and safety of two doses of enoxaparin in women with thrombophilia and recurrent pregnancy loss: the LIVE-ENOX study [J].
Brenner, B ;
Hoffman, R ;
Carp, H ;
Dulitsky, M ;
Younis, J .
JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2005, 3 (02) :227-229
[9]   Effects of enoxaparin on late pregnancy complications and neonatal outcome in women with recurrent pregnancy loss and thrombophilia: results from the Live-Enox study [J].
Brenner, B ;
Bar, J ;
Ellis, M ;
Yarom, I ;
Yohai, D ;
Samueloff, A .
FERTILITY AND STERILITY, 2005, 84 (03) :770-773
[10]   Clinical management of thrombophilia-related placental vascular complications [J].
Brenner, B .
BLOOD, 2004, 103 (11) :4003-4009